Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus (Q40444834)

20 September 2017

Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus (English)

1 reference

20 September 2017

0 references

0 references

1 reference

Karim Lee

1

1 reference

20 September 2017

Kipyoung Jeon

2

1 reference

20 September 2017

Jong-Mook Kim

3

1 reference

20 September 2017

Vic Narry Kim

4

1 reference

20 September 2017

Dong Hee Choi

5

1 reference

20 September 2017

Seung U Kim

6

1 reference

20 September 2017

Sunyoung Kim

7

1 reference

20 September 2017

1 July 2005

1 reference

20 September 2017

1 reference

20 September 2017

51

1 reference

20 September 2017

1

1 reference

20 September 2017

1-12

1 reference

Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

The immediate early genes of human cytomegalovirus upregulate expression of the cellular genes myc and fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

Cytomegalovirus in the brain: in vitro infection of human brain-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The cell biology of thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Cytomegalovirus infection decreases expression of thrombospondin-1 and -2 in cultured human retinal glial cells: effects of antiviral agents

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Thrombospondins and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Glial fibrillary acidic protein and induced differentiation of glia in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The relationship of glial fibrillary acidic protein to the shape, motility, and differentiation of human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

GFA and S 100 Protein Levels as an Index for Malignancy in Human Gliomas and Neurinomas2

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Modulation of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Antigen expression by glial cells grown in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Antisense oligonucleotide ISIS 2922 targets IE-expression and prevents HCMV-IE-induced suppression of TSP-1 and TSP-2 expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Use of retroviral vectors for gene transfer and expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Role of glial fibrillary acidic protein expression in the biology of human glioblastoma U-373MG cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Cell types involved in replication and distribution of human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Role of glial filaments in cells and tumors of glial origin: a review

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Specific inhibition of bcr-abl gene expression by small interfering RNA.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Suppression of glial tumor growth by expression of glial fibrillary acidic protein

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

The role of thrombospondin-1 in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

A stem-loop motif formed by the immediate 5' terminus of the bovine viral diarrhea virus genome modulates translation as well as replication of the viral RNA

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20179

7 January 2021

Identifiers

DOI

10.1002/GLIA.20179

1 reference

20 September 2017

1 reference